SCHEMBL23309563

SCHEMBL23309563

Cc1ccccc1OC(=O)c1cc(F)nc(F)c1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.47
▸ SERPINE1 P05121 1/20 0.46
▸ KMT2A Q03164 3/20 0.43
▸ MAPT P10636 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ ATM Q13315 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ RXRA P19793 1/20 0.40
▸ RXRB P28702 1/20 0.40
▸ RXRG P48443 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309657 0.84 TSHR (0.51) POLBSERPINE1KMT2AMAPTMEN1
SCHEMBL23309741 0.84 SERPINE1 (0.53) SERPINE1KMT2AMAPTSMN1; SMN2L3MBTL1
SCHEMBL23309626 0.81 NPSR1 (0.47) SERPINE1KMT2AMAPTMEN1SMN1; SMN2
SCHEMBL2831997 0.80 KMT2A (0.54) POLBKMT2AMAPTMEN1SMN1; SMN2
SCHEMBL23309684 0.80 ALOX5 (0.60) POLBSERPINE1KMT2AMAPTMEN1
SCHEMBL28678134 0.79 POLB (0.57) POLBSERPINE1KMT2AMAPTMEN1
SCHEMBL2835178 0.78 KMT2A (0.60) POLBKMT2AMAPTMEN1SMN1; SMN2
SCHEMBL1284160 0.78 KMT2A (0.63) POLBKMT2AMAPTMEN1SMN1; SMN2
SCHEMBL4736135 0.78 SERPINE1 (0.77) POLBSERPINE1KMT2AMAPTMEN1
SCHEMBL23309550 0.77 NSD2 (0.59) KMT2AMAPTMEN1ATMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL POLB 1411/4885SERPINE1 915/4885KMT2A 2360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback